In vivo half life of nanoencapsulated L-asparaginase

Baran, ET
Ozer, N
Hasırcı, Vasıf Nejat
In the present study, antileukemic enzyme L-asparaginase (ASNase) was encapsulated into poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanocapsules in order to decrease the immunogenicity and toxicity of the enzyme and to increase its in vivo half life in mice.
Citation Formats
E. Baran, N. Ozer, and V. N. Hasırcı, “In vivo half life of nanoencapsulated L-asparaginase,” pp. 1113–1121, 2002, Accessed: 00, 2020. [Online]. Available: